Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02167685 · ClinicalTrials.gov registry record
The Chimerix CMX001 Registry
A clinical trial, sponsored by Jazz Pharmaceuticals.
- Terminated
- Registry status
- 550
- Enrollment target
NCT02167685 is a clinical trial that was terminated before completion, run by Jazz Pharmaceuticals. The registered enrollment target is 550 participants.
The verdict
NCT02167685 was terminated before completion, sponsored by Jazz Pharmaceuticals.
- TERMINATED
- Registry status
- 550 participants
- Enrollment target
Study Summary
The prospective observational study is to establish a registry database to evaluate the potential impact of prior treatment with CMX001 on the long-term incidence of specific events, such as outcomes, late CMV and other Double-stranded DNA virus associated events, s well as survival rates in subjects previously enrolled in selected clinical studies of CMX001. Each Registry participant will be followed for a period of approximately 3 years from their enrollment in the Registry.
Interventions
- DRUG CMX001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2014-01 |
| Est. Completion | 2019-05-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02167685
The ClinicalTrials.gov registry entry for NCT02167685 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jazz Pharmaceuticals, which has 128 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CMX001 is the first listed.
NCT02167685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02167685 about?
NCT02167685 is a clinical study titled "The Chimerix CMX001 Registry". The prospective observational study is to establish a registry database to evaluate the potential impact of prior treatment with CMX001 on the long-term incidence of specific events, such as outcomes, late CMV and other Double-stranded DNA virus associated events, s well as survival rates in subject...
What is the current status of trial NCT02167685?
This trial is currently terminated. The enrollment target is 550 participants. The study started on 2014-01. Estimated completion is 2019-05-10.
What interventions are being tested in trial NCT02167685?
The interventions under investigation include: CMX001 (DRUG).
Who is sponsoring clinical trial NCT02167685?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.